Abstract

BackgroundTo complement ongoing schistosomiasis control within national control programmes (NCPs) that administer praziquantel to school-age children, assessing the risk and extent of schistosomiasis in pre-school-age children (PSAC) is important.MethodsIn June 2012, schistosomiasis in Chikhwawa district, Malawi was assessed across 12 villages examining pre-school-age children (PSAC) and their mothers by serological and parasitological diagnosis, as supplemented with urine-antigen and questionnaire-interview methods. Urinary tract morbidity was inferred by haematuria and albuminuria assays.ResultsIn total, 49.5% (CI95 42.6-56.4) of 208 PSAC and 94.5% (CI95 90.9-98.1) of 165 mothers were seropositive for schistosomiasis, in 2 villages seroprevalence exceeded 75% in PSAC. Egg-patent urogenital and intestinal schistosomiasis was observed; 17.7% (CI95 12.4-23.2) of PSAC and 45.1% (CI95 37.4-52.8) of mothers having active schistosomiasis by parasitological and urine-antigen testing combined. PSAC often had extensive daily water contact and many (~25%) had haematuria and albuminuria. As eggs with an atypical morphology of Schistosoma haematobium were observed, a general selection of schistosome eggs was characterized by DNA barcoding, finding Group I S. haematobium and Group IV and V S. mansoni. Malacological surveys encountered several populations of Bulinus globosus but failed to find Biomphalaria.ConclusionsBoth PSAC and their mothers appear to be at significant risk of schistosomiasis and should be considered for treatment within the NCP of Malawi.

Highlights

  • To complement ongoing schistosomiasis control within national control programmes (NCPs) that administer praziquantel to school-age children, assessing the risk and extent of schistosomiasis in pre-school-age children (PSAC) is important

  • Two major forms of schistosomiasis exist in sub-Saharan Africa (SSA), urogenital and intestinal, each caused by infection with different schistosome species, Schistosoma haematobium and S. mansoni, respectively [1]

  • Access to PZQ has expanded vastly in recent years [1,7,12] and in line with the WHO Strategic Plan for Control of Schistosomiasis, in the forthcoming 2012-2020 period, further scale-up of mass drug administration (MDA) is predicted in SSA with up to 250 million tablets earmarked each year for treatment of school-aged children (SAC) alone [11]

Read more

Summary

Introduction

To complement ongoing schistosomiasis control within national control programmes (NCPs) that administer praziquantel to school-age children, assessing the risk and extent of schistosomiasis in pre-school-age children (PSAC) is important. Two major forms of schistosomiasis exist in sub-Saharan Africa (SSA), urogenital and intestinal, each caused by infection with different schistosome species, Schistosoma haematobium and S. mansoni, respectively [1]. Whilst co-infection of both types of schistosomiasis is known, its extent remains poorly quantified but it is likely that several tens of millions live with both forms of disease [7] which may have permitted some ancestral genetic introgression between species previously [8]. Access to PZQ has expanded vastly in recent years [1,7,12] and in line with the WHO Strategic Plan for Control of Schistosomiasis, in the forthcoming 2012-2020 period, further scale-up of MDA is predicted in SSA with up to 250 million tablets earmarked each year for treatment of school-aged children (SAC) alone [11]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call